DDInter1778 DDInter1016
A drug formerly used as an antipsychotic but now used primarily in the symptomatic treatment of various hyperkinetic disorders. It is a monoamine depletor and used as symptomatic treatment of chorea associated with Huntington's disease. FDA approved on August 15, 2008.
Lactitol, also known as 4-β-D-galactopyranosyl-D-glucitol, is a sugar alcohol synthesized from [lactose]. It is used in food manufacturing as a nutritive sweetener and is approximately 35% as sweet as table sugar (i.e. [sucrose]). Clinically, lactitol has been investigated for use as an osmotic laxative and, along with other non-absorbable disaccharides such as [lactulose], in the treatment of hepatic encephalopathy in patients with cirrhosis.[A190915,A190918] Pizensy, an oral lactitol powder for solution, was approved by the FDA for use in chronic idiopathic constipation in February 2020.
Tetrabenazine {u} (Compound) resembles {v} (Compound) Donepezil
Tetrabenazine {u} (Compound) binds {v} (Gene) CYP2D6
Tetrabenazine {u} (Compound) upregulates {v} (Gene) WDR61
Tetrabenazine {u} (Compound) is included by {v} (Pharmacologic Class) Vesicular Monoamine Transporter 2 Inhibitors
Tetrabenazine {u} (Compound) downregulates {v} (Gene) GJA1
Tetrabenazine {u} (Compound) causes {v} (Side Effect) Insomnia
Tetrabenazine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Metronidazole
Tetrabenazine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Oxaliplatin
Tetrabenazine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Rolapitant
Tetrabenazine {u} may lead to a major life threatening interaction when taken with {v} Osimertinib
Tetrabenazine (Compound) resembles Donepezil (Compound)
Tetrabenazine (Compound) binds CYP2D6 (Gene)
Tetrabenazine (Compound) upregulates WDR61 (Gene)
Tetrabenazine (Compound) is included by Vesicular Monoamine Transporter 2 Inhibitors (Pharmacologic Class)
Tetrabenazine (Compound) downregulates GJA1 (Gene)
Tetrabenazine (Compound) causes Insomnia (Side Effect)
Tetrabenazine may cause a minor interaction that can limit clinical effects when taken with Metronidazole
Tetrabenazine may cause a moderate interaction that could exacerbate diseases when taken with Oxaliplatin
Tetrabenazine may cause a moderate interaction that could exacerbate diseases when taken with Rolapitant
Tetrabenazine may lead to a major life threatening interaction when taken with Osimertinib